ScreenerHero

TVGNTevogen Bio Holdings Inc. Common Stock

NAS · US · Healthcare · Biotechnology · tevogen.com
6.750USD+5.14%Mkt Cap: 43.95M $P/E: —

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, wh…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap43.95M $
Enterprise Value46.35M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.28M $
Revenue/Share—
Last Price6.750 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.21
EV/Revenue—
P/S—
P/B-1.42
EPS (TTM)-6.23
EPS (Forward)—
52W Range
3.6367% of range49.50
52W High49.50 USD
52W Low3.636 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE319.08%
ROA-599.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.33M $
CapEx (TTM)64.44K $
FCF Margin—
FCF Yield-7.21%
Net Debt8.78M $
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity-0.91
Current Ratio0.29
Quick Ratio0.12
Book Value/Sh-4.4720 USD
Cash/Share0.1650 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMar 6, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.51M
Float1.07M
Insiders68.15%
Institutions1.69%
Short Interest
Short Ratio4.2d
Short % Float4.44%
Short % Out.1.62%
Shares Short68.55K
Short (prev mo.)65.39K
Technical
SMA 506.706 (+0.7%)
SMA 20011.61 (-41.9%)
Beta0.20
S&P 52W Chg18.16%
Avg Vol (30d)13.37K
Avg Vol (10d)7.76K
Technical Indicators
RSI (14)54.8
MACD0.1113
MACD Signal0.0291
MACD Hist.+0.0821
BB Upper7.834 USD
BB Middle6.314 USD
BB Lower4.795 USD
BB Width48.14%
ATR (14)0.6514 USD
Vol Ratio (20d)1.09x